Navigation Links
Positive Results Using Affitech-Identified Human Antibody That,Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model,Reported by Peregrine

OSLO, Norway--(BUSINESS WIRE)--Apr 23, 2007 - Affitech AS, the human antibody therapeutics company announced today that Peregrine Pharmaceuticals, Inc. reported positive in vivo test results of R3, a fully human monoclonal antibody developed by Affitech, in a pancreatic cancer model at the recently concluded Centennial Annual Meeting of the American Association for Cancer Research (AACR). R3 has been designed by the two companies for selective blocking of VEGF (vascular endothelial growth factor) binding to VEGF receptor 2, as opposed to other anti-angiogenic agents which block activity of both VEGF receptors.

The R3 antibody, which was generated by Affitech's phagemid antibody library screening method, when tested by Peregrine on a pancreatic cancer model, showed significant reduction of the growth, vascularization and macrophage infiltration of pancreatic tumors in mice. This is the first antibody from Affitech's library that has been tested in a preclinical development model. Peregrine announced that the positive results of R3 antibody support the Company's intent to progress its anti-VEGF program towards clinical trials.

"We are delighted with this in vivo result, " commented Martin Welschof, Ph.D., Chief Executive Officer of Affitech. "Affitech and Peregrine have several collaborative antibody projects. The quality of the antibody and excellent collaborative research by the scientists of our two organizations are contributing to advancing Peregrine's anti-VEGF portfolio. This success also has important implications for accelerating our own human therapeutic antibody program "

Editors notes

Affitech AS is a privately held human therapeutic antibody discovery and development company with headquarters and R&D facilities in Oslo, Norway and its US subsidiary in the San Francisco Bay Area. The Company's current disease focus is oncology and it utilizes two discrete but unique approaches
'"/>




Page: 1 2

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Protox Announces Positive Clinical Data from Prostate Cancer Study
5. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
Post Your Comments:
(Date:5/29/2015)... , May 29, 2015  Epic Sciences announced today ... data, from metastatic castrate resistant prostate cancer patients, ... Society for Clinical Oncology. This application expands the ... left behind™ platform to characterize circulating tumor ... late stage patients have heterogeneous clonal CTC populations ...
(Date:5/28/2015)... -- Eli Lilly and Company (NYSE: LLY ) announced today ... for up to $1.6 billion aggregate principal amount of certain ... who tendered, and did not validly withdraw, their notes on ... time, on May 27, 2015 (the early tender date), ... to receive the total consideration. The total consideration for each ...
(Date:5/28/2015)...  Maetrics ( http://maetrics.com ), a leading international consulting ... a successful conference, "The cost of non-compliance -- How new ... Zurich . Hosted ... Switzerland -based team, experts provided insights on ... to an exclusive local audience. The event was held ...
Breaking Medicine Technology:Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 2Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 3Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 2Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 3Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 4Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 5Maetrics Hosts Innovative Medical Cluster Event in Switzerland 2
... Calif., Aug. 29, 2011 Bioness Inc., today announced the ... the U.S. Food and Drug Administration (FDA) earlier this year, ... Drop System with a thigh cuff to activate even more ... control while walking. The L300 Plus ...
... NxStage® Medical, Inc. (Nasdaq: NXTM ), ... announced that former NxStage® System One™ patient Tederra ... successful kidney transplant. Coleman, 33, of Pompano Beach, ... of daily home hemodialysis with the NxStage System ...
Cached Medicine Technology:Bioness Inc Announces Availability of L300 Plus System 2Former NxStage System One User Celebrates One-Year Kidney Transplant Anniversary 2Former NxStage System One User Celebrates One-Year Kidney Transplant Anniversary 3Former NxStage System One User Celebrates One-Year Kidney Transplant Anniversary 4
(Date:5/29/2015)... Jan Wooden Howse lost her husband and her son, ... God does no wrong. , It’s fitting, then, that her ... titled “God Does No Wrong.” It focuses on what happens ... , “My story has a positive message about channeling ... productive, something healing,” Howse said. , “God Does No Wrong” ...
(Date:5/29/2015)... 2015 Johnson & Johnson and ... Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ) settlement with a ... his use of the antipsychotic medication. According to ... the third bellwether trial to involve male breast ... in Pennsylvania’s Philadelphia Court of Common Pleas, where ...
(Date:5/29/2015)... May 29, 2015 A group of doctors ... joined the national effort to teach this “new math” to ... U.S. have been “sickened” by the recent implementation of Common ... or hate it, Common Core is now a reality in ... Parents are now seeking ways to improve common core ...
(Date:5/29/2015)... Intermountain Healthcare of Salt ... Stratus Video Interpreting for on-demand medical ... and timely care for patients with limited ... video remote interpreting (VRI) services will supplement ... quickly access qualified medical interpretation in nearly ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 The print ... with a circulation of approximately 250,000 and an estimated ... through a vast social media strategy, and across a ... explore the digital version of the campaign, click ... the print publication. Inside, the actress, model and producer ...
Breaking Medicine News(10 mins):Health News:Turning grief from a child’s passing into virtue 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 3Health News:Doctors Discover a Cure for the Common Core 2Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 2Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 3Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 4
... Inc.,announced today the appointment of Peter Crisafulli to the ... Mr. Crisafulli will support the,continued growth of NeoStrata,s existing ... the world. "I,m thrilled to be joining the ... company,s life," said Mr. Crisafulli, "I look forward,to helping ...
... From Insurers, Would Force All Americans,to Buy Private Coverage, ... Taxpayer and Consumer Rights (FTCR) today condemned Senator,Hillary Clinton,s ... that have given over $1 million in campaign contributions ... that would require every American to buy private,health insurance ...
... U.S. Department,of Health and Human Services agencies will ... prescription medications used to treat,attention deficit hyperactivity disorder ... attack, stroke or other cardiovascular problems. Researchers ... Quality,and the U.S. Food and Drug Administration will ...
... Features the bodybugg(TM) System-, SAN RAMON, Calif., Sept. ... popular unscripted reality series The Biggest Loser,will get some ... grand,prize, courtesy of 24 Hour Fitness. Participants in this ... calorie management system,designed to provide consumers with information and ...
... 17 Today in Des Moines,Iowa, Democratic presidential ... health care plan. A spokesperson for the,Employment Policies ... "Any plan that tries to achieve universal coverage ... bound to fail," said Jill Jenkins, chief,economist at ...
... 21 Poster Sessions ... Program , LOUISVILLE, Colo., Sept. 17 Replidyne, ... be presenting 21 posters,highlighting three major pipeline programs at ... (ICAAC) held at the,McCormick Place conference center in Chicago. ...
Cached Medicine News:Health News:The NeoStrata Company Appoints a New Vice President of Operations 2Health News:Consumer Group: Hillary Clinton's Mandatory Health Insurance Purchase Plan is an Act of War on the Middle Class Family That Can't Afford $12k Policy 2Health News:Consumer Group: Hillary Clinton's Mandatory Health Insurance Purchase Plan is an Act of War on the Middle Class Family That Can't Afford $12k Policy 3Health News:AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks with ADHD Medications 2Health News:AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks with ADHD Medications 3Health News:24 Hour Fitness Gives The Biggest Loser High-Tech Upgrade 2Health News:24 Hour Fitness Gives The Biggest Loser High-Tech Upgrade 3Health News:Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 2Health News:Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 3Health News:Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 4Health News:Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 5
The Onyx® 9500 worlds first self-contained digital fingertip pulse oximeter incorporates the electronics and the sensor into one unit....
The SportStat Pulse Oximeter shines red and infrared light through a finger and detects the fluctuating signals caused by blood flow. Pulse rate is determined from the signals received by a light det...
Ergonomically designed, the Invacare Printing Pulse Oximeter provides fast, reliable spot-check information and documentation of SpO2 and pulse rate. It is ideal for all patients from neonate to adul...
The FetalSAT™ System with DualSens Sensor displays continuous, real-time fetal pulse oximetry (FSpO2) and fetal pulse rate (FPR) values in one compact monitor....
Medicine Products: